BST2 and Miyoshi myopathy: However, based on the above studies, the encapsulation of MM-specific antigens (such as BCMA, HM1.24 and MUC) in exosomes or DC-EXs with myeloma-specific antigens as cell-free vaccines are promising, and need to be further investigated in the hope of improving the efficacy of therapeutic vaccines for MM.